E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/22/2011 in the Prospect News PIPE Daily.

NeurogesX to pocket $20.21 million through private placement of units

Offering consists of units of one common share, a half-share warrant

By Devika Patel

Knoxville, Tenn., July 22 - NeurogesX, Inc. said it arranged a $20.21 million private placement of units on Thursday.

The company will sell 11,749,552 units of one common share and a half-share warrant at $1.72 per unit.

The whole warrants are exercisable at $1.65for five years. The strike price is identical to the July 21 closing share price.

Leerink Swann LLC is the agent.

NeurogesX is a San Mateo, Calif.-based biopharmaceutical company.

Issuer:NeurogesX, Inc.
Issue:Units of one common share and a half-share warrant
Amount:$20,209,229
Units:11,749,552
Price:$1.72
Warrants:One half-share warrant per unit
Warrant expiration:Five years
Warrant strike price:$1.65
Agents:Leerink Swann LLC
Pricing date:July 21
Settlement date:Feb. 4
Stock symbol:Nasdaq: NGSX
Stock price:$1.65 at close July 21
Market capitalization:$28.42 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.